Albers Jeffrey W. bought KYMR
December 8, 2025 · Form 4 insider transaction
Albers Jeffrey W. bought 5,000 shares of Kymera Therapeutics, Inc. at $14.18 per share, a transaction worth $70.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$14.18
Total value
$70.9K
InsiderAlbers Jeffrey W.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 8, 2025
Shares owned after5,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 20, 2024 adopted by the reporting person.